113 related articles for article (PubMed ID: 7720838)
1. Haemostatic and fibrinolytic parameters in septic patients with leukopenia or leukocytosis.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Yoshida T; Aoshima K; Matsuda T
Eur J Haematol; 1995 Mar; 54(3):176-9. PubMed ID: 7720838
[TBL] [Abstract][Full Text] [Related]
2. Alterations in coagulation and fibrinolysis during sepsis.
Kidokoro A; Iba T; Fukunaga M; Yagi Y
Shock; 1996 Mar; 5(3):223-8. PubMed ID: 8696988
[TBL] [Abstract][Full Text] [Related]
3. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
[TBL] [Abstract][Full Text] [Related]
4. Influence of white blood cells on the fibrinolytic response to sepsis: studies of septic patients with or without severe leucopenia.
Haj MA; Neilly IJ; Robbie LA; Adey GD; Bennett B
Br J Haematol; 1995 Jul; 90(3):541-7. PubMed ID: 7646991
[TBL] [Abstract][Full Text] [Related]
5. Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis.
Mesters RM; Flörke N; Ostermann H; Kienast J
Thromb Haemost; 1996 Jun; 75(6):902-7. PubMed ID: 8822584
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis.
López-Aguirre Y; Páramo JA
Thromb Res; 1999 Apr; 94(2):95-101. PubMed ID: 10230894
[TBL] [Abstract][Full Text] [Related]
7. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
[TBL] [Abstract][Full Text] [Related]
8. Relationship between elevation in the plasma concentration of elastase-alpha 1 proteinase inhibitor complex (E-alpha 1 PI) and haemostatic parameters during haemodialysis.
Yamazaki M; Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Aoshima K; Sato T; Tsugawa Y
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):5-10. PubMed ID: 7795153
[TBL] [Abstract][Full Text] [Related]
9. Role of leukocytes in the activation of intravascular coagulation in patients with septicemia.
Okajima K; Yang WP; Okabe H; Inoue M; Takatsuki K
Am J Hematol; 1991 Apr; 36(4):265-71. PubMed ID: 1707228
[TBL] [Abstract][Full Text] [Related]
10. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
Mehta P; Parker RI
J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
[TBL] [Abstract][Full Text] [Related]
11. White coat hypertension and haemostatic/fibrinolytic balance disorders.
Makris T; Stavroulakis G; Papadopoulos D; Paizis I; Krespi P; Tsoukala C; Hatzizacharias A; Votteas V
Eur Cytokine Netw; 2006 Jun; 17(2):137-41. PubMed ID: 16840033
[TBL] [Abstract][Full Text] [Related]
12. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
13. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin.
Katayama S; Nunomiya S; Koyama K; Wada M; Koinuma T; Goto Y; Tonai K; Shima J
Crit Care; 2017 Aug; 21(1):229. PubMed ID: 28841902
[TBL] [Abstract][Full Text] [Related]
14. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
15. [Leukemia and pre-DIC--coagulation and fibrinolytic parameters in severe infection at the nadir of leukocyte after chemotherapy].
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Rinsho Byori; 1990 Jul; Suppl 86():158-63. PubMed ID: 2232237
[No Abstract] [Full Text] [Related]
16. Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia.
Wada H; Mori Y; Kaneko T; Wakita Y; Nakase T; Minamikawa K; Ohiwa M; Tamaki S; Tanigawa M; Kageyama S
Am J Hematol; 1993 Oct; 44(2):112-6. PubMed ID: 8266915
[TBL] [Abstract][Full Text] [Related]
17. The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome.
Ames PR; Lupoli S; Alves J; Atsumi T; Edwards C; Iannaccone L; Khamashta MA; Hughes GR; Brancaccio V
Br J Rheumatol; 1997 Oct; 36(10):1045-50. PubMed ID: 9374919
[TBL] [Abstract][Full Text] [Related]
18. Haemostatic parameters in patients with primitive venous hypertension.
Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Attina A; Soraci S; Bagnato L; Barbera N
Panminerva Med; 1997 Jun; 39(2):100-2. PubMed ID: 9230618
[TBL] [Abstract][Full Text] [Related]
19. The role of fibrinolytic and antifibrinolytic activities in the pathophysiology of HELLP syndrome.
Guven S; Sonmez M; Karahan SC
Hypertens Pregnancy; 2011; 30(3):275-86. PubMed ID: 19943771
[TBL] [Abstract][Full Text] [Related]
20. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
